Acadia Healthcare Company, Inc. ACHC

Health CareHealthcare Providers & ServicesUnited States of America

Last close 29.62 USD on Nov 2, 2026, +108.7% year to date

Quant rating

Quant rating B Rank 187 of 565 in Health Care

Growth B 154 of 565
Valuation C 353 of 565
Quality C 230 of 565
Revisions B 168 of 565
Momentum C 253 of 565

Wall Street consensus Buy (2.36)Average target 33.79 USD +14.1%

Historical valuation

Multiples use consensus estimates for the next twelve months. The dashed line is the 5-year average.

Key data

Market cap: 2.8B
Enterprise value: 5.2B
52-week range: 11.44 – 35.80
3-year range: 11.44 – 87.38
Dividend yield: –
Beta (5 years): 0.63
Shares outstanding: 93.1M
Next earnings: Nov 4, 2026

About the company

Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services. The Company owns and operates acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers (CTCs), residential treatment centers and facilities providing outpatient behavioral healthcare services to serve the behavioral healthcare and recovery needs of communities throughout the United States and Puerto Rico. Its acute inpatient psychiatric facilities provide a high level of care in order to stabilize patients that are either a threat to themselves or to others. Its CTCs specialize in providing medication-assisted treatment in an outpatient setting. Its specialty treatment facilities primarily consist of residential recovery facilities. It provides a comprehensive continuum of care for adults with addictive disorders and co-occurring mental disorders. Its residential treatment centers treat patients with behavioral disorders in a non-hospital setting.

Growth and profitability fiscal year ends December 31

Growth and profitability by fiscal year
	2025	2024	2023	2022	2021	5Y avg
Revenue (mil)	3,313	3,154	2,929	2,610	2,314	–
Revenue growth	5.0%	7.7%	12.2%	12.8%	10.7%	9.7%
EPS (basic, normalized)	2.00	3.30	3.44	3.01	2.56	–
EPS growth	−39.4%	−4.1%	14.3%	17.6%	–	–
Gross margin	–	–	–	–	–	–
Net margin	−33.3%	8.1%	−0.7%	10.5%	8.8%	−1.3%
ROE	−43.9%	8.7%	−0.8%	10.2%	9.2%	−3.3%

Balance sheet, last quarter
Cash & short-term investments (mil)	171
Current ratio	1.57x
Long-term debt (mil)	2,382
Net debt (mil)	2,457
Total equity (mil)	1,979
Net debt / equity	1.24x
Net debt / EBITDA	4.04x

Estimates and valuation

Consensus estimates and implied multiples
	Sales (mil)			EBITDA (mil)			EPS
Fiscal year	Mean est.	Growth	EV/Sales	Mean est.	Growth	EV/EBITDA	Mean est.	Growth	P/E
2025 actual	3,313	+5.0%	1.6x	609	−15.7%	8.6x	2.00	−39.4%	14.8x
2026	3,429	+3.5%	1.5x	599	−1.6%	8.7x	1.55	−22.4%	19.1x
2027	3,633	+6.0%	1.4x	645	+7.6%	8.1x	1.85	+18.9%	16.0x
2028	3,835	+5.6%	1.4x	695	+7.7%	7.5x	2.13	+15.6%	13.9x

Estimate revisions

Change in consensus estimates over 1, 3 and 6 months
	Sales				EPS
Fiscal year	Estimate (mil)	1M	3M	6M	Estimate	1M	3M	6M
2026	3,429	0.0%	0.0%	+0.6%	1.55	0.0%	0.0%	+2.9%
2027	3,633	0.0%	0.0%	+0.6%	1.85	0.0%	+1.4%	+5.4%
2028	3,835	0.0%	0.0%	+0.1%	2.13	0.0%	+1.6%	+8.0%

Earnings surprises EPS beat in 4 of the last 4 quarters

Reported results versus consensus, last 10 fiscal quarters
Quarter ended	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales reported (mil)	768	796	816	774	771	869	852	821	829	866
Sales mean (mil)	779	784	819	779	770	840	846	800	823	844
Surprise	−1.4%	+1.5%	−0.5%	−0.6%	+0.1%	+3.5%	+0.7%	+2.7%	+0.7%	+2.6%
EPS reported	0.84	0.91	0.91	0.64	0.40	0.83	0.72	0.07	0.37	0.38
EPS mean	0.81	0.87	0.90	0.71	0.36	0.69	0.67	0.06	0.27	0.35
Surprise	+4.2%	+4.5%	+0.7%	−10.5%	+12.1%	+19.5%	+7.4%	+20.7%	+39.1%	+9.5%

Peer comparison Healthcare Providers & Services

Peers in the same industry group, by market capitalization
Company	Market cap	Net debt/EBITDA	Net margin	P/B	FY1 P/E	FY2 P/E	FY1 EV/EBITDA	FY2 EV/EBITDA
ACHC Acadia Healthcare Company, Inc.	2.8B	4.04x	−33.3%	1.36x	19.1x	16.0x	8.7x	8.1x
UNH UnitedHealth Group Incorporated	359.4B	–	2.7%	3.45x	19.4x	17.1x	13.1x	11.9x
CVS CVS Health Corporation	113.2B	2.50x	0.4%	1.42x	11.0x	10.4x	8.3x	7.9x
HCA HCA Healthcare, Inc.	97.7B	3.41x	9.0%	−12.21x	15.6x	14.9x	9.5x	9.4x
ELV Elevance Health Inc	89.4B	–	2.8%	2.00x	14.2x	13.7x	10.0x	10.3x
CI The Cigna Group	78.0B	2.49x	2.2%	1.83x	9.7x	8.8x	7.7x	7.2x
Mean		3.11x	−2.7%	−0.36x	14.8x	13.5x	9.5x	9.1x
Median		2.96x	2.4%	1.62x	14.9x	14.3x	9.1x	8.8x

Technical analysis

1M+5.6%
3M0.0%
1Y+37.8%
3Y−59.6%

Financial statements in millions of USD

Income statement in millions of USD, fiscal years

Income statement, Acadia Healthcare Company, Inc., fiscal years, most recent first
	2025	2024	2023	2022	2021	2020
Total revenue	3,313	3,154	2,929	2,610	2,314	2,090
Cost of revenue	–	–	–	–	–	–
Gross profit	3,313	3,154	2,929	2,610	2,314	2,090
Selling, general & administrative expenses	2,182	2,041	1,901	1,697	1,510	1,400
Research & development	–	–	–	–	–	–
Depreciation/amortization	189	150	132	118	107	95.3
Interest expense (income), operating	–	–	–	–	–	–
Unusual expense (income)	1,324	64.0	460	2.3	43.8	23.7
Other operating expenses	553	441	389	349	301	262
Operating income	−936	458	47.0	444	353	309
Net interest income (expense)	−139	−116	−82.1	−69.8	−77.0	−158
Gain (loss) on sale of assets	8.7	0	9.7	–	–	–
Other non-operating income (expense)	0	0	0	0	0	32.8
Net income before taxes	−1,066	342	−25.4	374	276	184
Provision for taxes	26.0	77.4	−9.7	94.1	67.6	40.6
Minority interest	−10.8	−8.9	−6.0	−6.9	−4.9	−2.9
Equity in affiliates	–	–	–	–	–	–
U.S. GAAP adjustment	–	–	–	–	–	–
Net income before extraordinary items	−1,103	256	−21.7	273	203	140
Extraordinary items	–	–	0	0	−12.6	−812
Net income	−1,103	256	−21.7	273	191	−672
EBIT, normalized	388	522	507	446	397	333
EBITDA, normalized	577	672	639	564	503	428
Basic EPS, normalized	2.00	3.30	3.44	3.01	2.56	–

Balance sheet in millions of USD, fiscal years

Balance sheet, Acadia Healthcare Company, Inc., fiscal years, most recent first
	2025	2024	2023	2022	2021	2020
Assets
Cash & short-term investments	133	76.3	100	97.6	134	379
Receivables	514	422	430	354	304	297
Total inventory	5.7	5.7	5.3	5.1	4.8	4.9
Prepaid expenses	47.0	41.4	36.1	27.1	22.3	19.5
Other current assets	115	32.2	25.0	22.6	29.7	1,823
Total current assets	814	577	596	506	495	2,523
Property, plant & equipment	3,245	2,972	2,384	2,087	1,905	1,720
Goodwill	1,296	2,265	2,226	2,223	2,200	2,105
Intangibles	96.7	70.0	73.3	76.0	70.1	68.5
Long-term investments	–	–	–	–	–	–
Note receivable	–	–	–	–	–	–
Other long-term assets	75.1	73.0	79.2	95.6	98.0	82.3
Total assets	5,527	5,957	5,359	4,988	4,768	6,499
Liabilities
Accounts payable	150	233	156	105	98.6	87.8
Payable/accrued	–	–	–	–	–	–
Accrued expenses	311	252	676	219	220	223
Short-term debt	0	0	0	0	0	0
Current portion of long-term debt	29.5	77.9	30.2	22.2	19.6	186
Other current liabilities	34.2	15.0	23.9	42.8	67.0	812
Total current liabilities	525	578	886	388	405	1,308
Long-term debt	2,482	1,891	1,353	1,375	1,489	2,980
Minority interest	192	117	106	88.3	65.4	55.3
Other liabilities	379	297	232	323	291	257
Total liabilities	3,578	2,883	2,577	2,175	2,251	4,600
Shareholders' equity
Preferred stock	0	0	0	0	–	–
Common stock	0.9	0.9	0.9	0.9	0.9	0.9
Additional paid-in capital	2,714	2,685	2,649	2,658	2,636	2,580
Retained earnings (accumulated deficit)	−766	387	132	153	−120	−310
Treasury stock	–	–	–	–	–	–
Other equity	0	0	0	0	0	−371
Total equity	1,949	3,074	2,782	2,813	2,517	1,899
Total liabilities & shareholders' equity	5,527	5,957	5,359	4,988	4,768	6,499

Cash flow statement in millions of USD, fiscal years

Cash flow statement, Acadia Healthcare Company, Inc., fiscal years, most recent first
	2025	2024	2023	2022	2021	2020
Operating activities
Net income	−1,092	264	−15.7	280	196	−669
Depreciation, depletion & amortization	189	150	132	118	107	95.3
Deferred taxes	1.1	67.7	−94.0	16.5	11.8	53.1
Non-cash items	1,042	53.8	433	35.6	104	941
Changes in working capital	−8.7	−406	6.6	−69.4	−43.5	163
Cash from operations	132	130	462	381	374	584
Investing activities
Capital expenditures	−572	−690	−424	−296	−245	−225
Other investing cash flows	15.6	−46.1	26.9	−9.7	1,258	−56.9
Cash from investing	−556	−736	−397	−306	1,013	−282
Financing activities
Financing cash flow items	−19.7	−0.7	−46.4	2.7	4.4	−25.6
Cash dividends paid	–	–	–	–	–	–
Issuance (retirement) of debt, net	–	–	–	–	–	–
Other financing cash flows	501	584	−16.2	−114	−1,641	−25.9
Cash from financing	481	583	−62.7	−111	−1,637	−51.5
Foreign exchange effects	–	–	0	0	4.1	4.1
Net change in cash	56.9	−23.8	2.4	−36.2	−245	255
Free cash flow	−440	−561	38.2	84.4	130	359

Disclaimer

The financial data presented in this report is delayed and obtained from sources QDD Research believes to be reliable, including stock exchanges, SEDAR, and EDGAR. However, no representation or warranty is made as to the accuracy, completeness, or timeliness of the information. QDD Research accepts no liability for any errors, omissions, or financial losses arising from the use of this data.

This report is generated using a fully systematic and quantitative approach. All factor scores and the overall quant rating (ranging from D to A+) are derived from algorithmic models and are based solely on objective financial metrics. These scores are intended for informational purposes only and should not be interpreted as investment advice or a recommendation to buy, sell, or hold any securities.

QDD Research is not a registered investment advisor or broker-dealer and does not provide personalized financial advice. The content is not tailored to the specific investment goals, financial situation, or risk profile of any individual investor. We strongly encourage readers to consult with a licensed broker or investment advisor before making any investment decisions based on the information contained in this report.

Live quote provided by TradingView. Report data updated Nov 2, 2026 after market close.